About Minerva (NERV)
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS) diseases. Th... Read more
- USD2.59
- USD2.59
- USD2.49
- USD13.49
- -5.20%
- --
- 19.26k
- 17M
- 2.29
- 2.80%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
